At its April 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) gave ...

The case report by cardiologist Mahmoud Gomaa and colleagues from Kafrelsheikh University Hospital in Kafr el-Sheikh, Egypt, highlighted the potential complications of acromegaly. The patient ...

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).